A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCRâ€' B cells

Autor: Mary Ellen Conley, Tatiana Kochetkov, Stuart G. Tangye, Bertrand Boisson, Yong-Dong Wang, Cindy S. Ma, Annick Lim, Amma Bosompem, Jean-Laurent Casanova
Rok vydání: 2013
Předmět:
Zdroj: Journal of Clinical Investigation. 123:4781-4785
ISSN: 0021-9738
DOI: 10.1172/jci71927
Popis: Approximately 90% of patients with isolated agammaglobulinemia and failure of B cell development have mutations in genes required for signaling through the pre–B cell and B cell receptors. The nature of the gene defect in the majority of remaining patients is unknown. We recently identified 4 patients with agammaglobulinemia and markedly decreased numbers of peripheral B cells. The B cells that could be detected had an unusual phenotype characterized by the increased expression of CD19 but the absence of a B cell receptor. Genetic studies demonstrated that all 4 patients had the exact same de novo mutation in the broadly expressed transcription factor E47. The mutant protein (E555K) was stable in patient-derived EBV-transformed cell lines and cell lines transfected with expression vectors. E555K in the transfected cells localized normally to the nucleus and resulted in a dominant negative effect when bound to DNA as a homodimer with wild-type E47. Mutant E47 did permit DNA binding by a tissue-specific heterodimeric DNA-binding partner, myogenic differentiation 1 (MYOD). These findings document a mutational hot-spot in E47 and represent an autosomal dominant form of agammaglobulinemia. Further, they indicate that E47 plays a critical role in enforcing the block in development of B cell precursors that lack functional antigen receptors.
Databáze: OpenAIRE